The Diverse Ethics of Translational Research

被引:24
|
作者
Sofaer, Neema [1 ]
Eyal, Nir [2 ,3 ]
机构
[1] Kings Coll London, Ctr Med Law & Eth, London WC2R 2LS, England
[2] Harvard Univ, Sch Med, Div Med Eth, Cambridge, MA 02138 USA
[3] Harvard Univ, Program Eth & Hlth, Cambridge, MA 02138 USA
来源
AMERICAN JOURNAL OF BIOETHICS | 2010年 / 10卷 / 08期
关键词
clinical trials; developing countries; ethical review; ethics; health services research; implementation science; phase IV clinical trials; translational research; GENE-TRANSFER; PUBLIC-HEALTH; CLINICAL-TRIALS; THERAPY; SCIENCE; COMMITTEES; OBSTACLES; BEDSIDE; JUSTICE; BENCH;
D O I
10.1080/15265161.2010.494214
中图分类号
B82 [伦理学(道德学)];
学科分类号
摘要
Commentators on the ethics of translational research find it morally problematic. Types of translational research are said to involve questionable benefits, special risks, additional barriers to informed consent, and severe conflicts of interest. Translational research conducted on the global poor is thought to exploit them and increase international disparities. Some commentators support especially stringent ethical review. However, such concerns are grounded only in pre-approval translational research (now called T1). Whether or not T1 has these features, translational research beyond approval (T2: phase IV, health services, and implementation research) is unlikely to and, when conducted on the global poor, may support development. Therefore, insofar as T1 is morally problematic, and no independent objections to T2 exist, the ethics of translational research is diverse: while some translational research is problematic, some is not. Funding and oversight should reflect this diversity, and T2 should be encouraged, particularly when conducted among the global poor.
引用
收藏
页码:19 / 30
页数:12
相关论文
共 50 条
  • [31] Nonhuman Primate Models of Stroke for Translational Neuroprotection Research
    Cook, Douglas J.
    Tymianski, Michael
    NEUROTHERAPEUTICS, 2012, 9 (02) : 371 - 379
  • [32] Optimising Translational Research Opportunities: A Systematic Review and Narrative Synthesis of Basic and Clinician Scientists' Perspectives of Factors Which Enable or Hinder Translational Research
    Fudge, Nina
    Sadler, Euan
    Fisher, Helen R.
    Maher, John
    Wolfe, Charles D. A.
    McKevitt, Christopher
    PLOS ONE, 2016, 11 (08):
  • [33] ETHICS AND LEGAL KEYS TO BIOMEDICAL RESEARCH IN SPAIN
    Cabanillas Sanchez, Antonio
    Zavala, Jorge
    AGE OF HUMAN RIGHTS JOURNAL, 2014, (02): : 51 - 67
  • [35] Ethics and equity in rare disease research and healthcare
    Koromina, Maria
    Fanaras, Vasileios
    Baynam, Gareth
    Mitropoulou, Christina
    Patrinos, George P.
    PERSONALIZED MEDICINE, 2021, 18 (04) : 407 - 416
  • [36] Research ethics or ethics research?
    Brighi, Antonella
    Laghi, Fiorenzo
    Ligorio, Beatrice
    Milani, Luca
    Palladino, Benedetta Emanuela
    Zanetti, Maria Assunta
    PSICOLOGIA CLINICA DELLO SVILUPPO, 2021, 25 (02) : 276 - 278
  • [37] New hurdles for translational research
    Mitch Dowsett
    Breast Cancer Research, 2
  • [38] Translational Research in Neurology Dementia
    Honig, Lawrence S.
    ARCHIVES OF NEUROLOGY, 2012, 69 (08) : 969 - 977
  • [39] New hurdles for translational research
    Dowsett, M
    BREAST CANCER RESEARCH, 2000, 2 (04) : 241 - 243
  • [40] Translational Research: A Concept Analysis
    Wendler, M. Cecilia
    Kirkbride, Geri
    Wade, Kristen
    Ferrell, Lynne
    RESEARCH AND THEORY FOR NURSING PRACTICE, 2013, 27 (03) : 214 - 232